ARCHIVES

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

Adjuvant BC Therapy Is Topic Of NIH Consensus Conference.

January 28, 2000

Kennedy Bill Would Extend Cancer Program Three Years, Kill Budget Bypass

May 4, 1979

Manipulating The Therapeutic Index Clinical Trials Goal: Hellman

June 13, 1980

In Brief: Wells Tapped For GM Cancer Foundation; Calder Named NABCO Associate Director

January 17, 1997

NCAB Subcommittee Worries About Board’s Makeup

January 19, 1979

In Brief: Fishman La Jolla President Emeritus, Ruoslahti Succeeds Him; Ariz. Seeks Meyskins Replacement

January 13, 1989